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Summary {#efs25409-sec-0001}
=======

Fluquinconazole was approved on 1 January 2012 by means of Commission Implementing Regulation (EU) No 806/2011 under Regulation (EC) No 1107/2009 as amended by Commission Implementing Regulations (EU) No 540/2011 and 541/2011. As the active substance was approved after the entry into force of Regulation (EC) No 396/2005 on 2 September 2008, the European Food Safety Authority (EFSA) is required to provide a reasoned opinion on the review of the existing maximum residue levels (MRLs) for that active substance in compliance with Article 12(1) of the aforementioned regulation.

As the basis for the MRL review, on 16 August 2017, EFSA initiated the collection of data for this active substance. In a first step, Member States were invited to submit their national Good Agricultural Practices (GAPs) by 15 September 2017, in a standardised way, in the format of specific GAP forms, in the format of specific GAP overview file. According to the information provided in the GAP forms no uses are currently authorised for fluquinconazole in the Member States. Moreover, the rapporteur Member State (RMS) did not report any uses authorised in third countries that might have a significant impact on international trade.

On the basis of all the data submitted by Member States, EFSA, according to the process, should in principle ask Ireland as the designated RMS, to complete the Pesticide Residues Overview File (PROFile) and to prepare a supporting evaluation report. The evaluation report was provided by the RMS to EFSA on 21 December 2017. Nevertheless, since neither European Union (EU) uses nor import tolerances are currently authorised for fluquinconazole, a GAP overview file and a PROFile were not considered relevant and were not submitted.

Following a scientific check on the data submitted undertaken by EFSA, no additional clarification/amendment were needed and, on 9 February 2018, the RMS was directly informed of the completeness of the information received.

Based on the information provided by the RMS, Member States and the EU Reference Laboratories for Pesticides Residues and taking into account the conclusions derived by EFSA in the framework of Directive 91/414/EEC, EFSA prepared in June 2018 a draft reasoned opinion, which was circulated to Member States for consultation via a written procedure. Comments received by 30 July 2018 were considered during the finalisation of this reasoned opinion. The following conclusions are derived.

Residues of fluquinconazole are not expected to occur in any plant commodity or in any animal product because no uses or import tolerances are currently authorised for fluquinconazole in the EU and no codex maximum residue limits (CXLs) are available for this active substance. A risk assessment is therefore in principle not required.

Nevertheless, in order to assist risk managers in applying the most appropriate enforcement measures (against potential illegal uses), EFSA assessed the available data with particular attention to the analytical methods and the nature of residues in plants and livestock.

According to the results from the available metabolism studies in primary, rotational crops and in animals, parent compound is considered to be the most adequate marker for enforcement against the potential illegal use of fluquinconazole. It is expected that this compound can be enforced with an limit of quantification (LOQ) of 0.01 mg/kg in all animal and plant commodities, except in complex matrices (e.g. tea, herbal infusions, cocoa, hops and spices). For these plant commodities, in the absence of fully validated analytical method, a higher LOQ of 0.05 mg/kg is tentatively proposed.

Since in the metabolism studies performed with dichlorophenyl‐labelled fluquinconazole, residues present in fat and in milk were almost exclusively represented by the parent molecule, this residue is to be considered as fat soluble.

Considering that the enforcement against potential illegal uses falls under the remit of risk managers, EFSA is not in a position to recommend whether the default MRL of 0.01 mg/kg, as defined by Regulation (EC) No 396/2005, or whether the setting of specific LOQ values for plant and animal commodities should apply. It is noted however that for fluquinconazole, LOQ values of 0.05 mg/kg in complex matrices of plant origin and of 0.01 mg/kg in all other plant commodities and in animal commodities, would provide a satisfactory level of protection for European consumers.

Background {#efs25409-sec-0003}
==========

Regulation (EC) No 396/2005[1](#efs25409-note-1005){ref-type="fn"} (hereinafter referred to as 'the Regulation') establishes the rules governing the setting and the review of pesticide maximum residue levels (MRLs) at European level. Article 12(1) of that Regulation stipulates that the European Food Safety Authority (EFSA) shall provide within 12 months from the date of the inclusion or non‐inclusion of an active substance in Annex I to Directive 91/414/EEC[2](#efs25409-note-1006){ref-type="fn"} a reasoned opinion on the review of the existing MRLs for that active substance. As fluquinconazole was approved on 1 January 2012 by means of Commission Implementing Regulation (EU) No 806/2011[3](#efs25409-note-1007){ref-type="fn"} under Regulation (EC) No 1107/2009[4](#efs25409-note-1008){ref-type="fn"} as amended by Commission Implementing Regulations (EU) No 540/2011[5](#efs25409-note-1009){ref-type="fn"} and 541/2011[6](#efs25409-note-1010){ref-type="fn"}, EFSA initiated the review of all existing MRLs for that active substance.

According to the legal provisions, EFSA shall base its reasoned opinion in particular on the relevant assessment report prepared under Directive 91/414/EEC. It should be noted, however, that, in the framework of Directive 91/414/EEC, only a few representative uses are evaluated, whereas MRLs set out in Regulation (EC) No 396/2005 should accommodate all uses authorised within the European Union (EU), and uses authorised in third countries that have a significant impact on international trade. The information included in the assessment report prepared under Directive 91/414/EEC is therefore insufficient for the assessment of all existing MRLs for a given active substance.

To gain an overview of the pesticide residues data that have been considered for the setting of the existing MRLs, EFSA developed the Pesticide Residues Overview File (PROFile). The PROFile is an inventory of all pesticide residues data relevant to the risk assessment and MRL setting for a given active substance. This includes data on: the nature and magnitude of residues in primary crops;the nature and magnitude of residues in processed commodities;the nature and magnitude of residues in rotational crops;the nature and magnitude of residues in livestock commodities;the analytical methods for enforcement of the proposed MRLs.

As the basis for the MRL review, on 16 August 2017, EFSA initiated the collection of data for this active substance. In a first step, Member States were invited to submit their national Good Agricultural Practices (GAPs) that are authorised in different Member States by 15 September 2017, in a standardised way in the format of specific GAP forms. In the framework of this consultation four Member States (the Czech Republic, Ireland, Germany and Poland) provided feedback on their national authorisations. An evaluation report was also submitted by the European Union Reference Laboratories for Pesticides Residues (EURLs, [2018](#efs25409-bib-0005){ref-type="ref"}). According to the information provided in the GAP forms, uses are no currently authorised for fluquinconazole in the Member States. Moreover, the rapporteur Member State (RMS) did not report any uses authorised in third countries that might have a significant impact on international trade.

On the basis of all the data submitted by Member States, EFSA, according to the process, should in principle ask Ireland as the designated RMS, to complete the Pesticide Residues Overview File (PROFile) and to prepare a supporting evaluation report. The evaluation report was provided by the RMS to EFSA on 21 December 2017. Nevertheless, since neither EU uses nor import tolerances are currently authorised for fluquinconazole, a GAP overview file and a PROFile were not considered relevant and were not submitted.

Following a scientific check on the data submitted undertaken by EFSA, no additional clarification/amendment were needed and, on 9 February 2018, the RMS was directly informed of the completeness of the information received.

Based on the information provided by the RMS, Member States and the EURLs and taking into account the conclusions derived by EFSA in the framework of Directive 91/414/EEC, EFSA prepared in June 2018 a draft reasoned opinion, which was circulated to Member States for consultation via a written procedure. Comments received by 30 July 2018 were considered during the finalisation of this reasoned opinion.

The evaluation report submitted by the RMS (Ireland, [2017](#efs25409-bib-0010){ref-type="ref"}) and the Member States consultation report (EFSA, [2018](#efs25409-bib-0004){ref-type="ref"}) are considered as supporting documents to this reasoned opinion and, thus, are made publicly available.

Furthermore, a screenshot of the Report sheet of the EFSA Pesticide Residues Intake Model (PRIMo) is presented in Appendix [C](#efs25409-sec-1004){ref-type="sec"}.

Terms of Reference {#efs25409-sec-0004}
==================

According to Article 12 of Regulation (EC) No 396/2005, EFSA shall provide a reasoned opinion on: the inclusion of the active substance in Annex IV to the Regulation, when appropriate;the necessity of setting new MRLs for the active substance or deleting/modifying existing MRLs set out in Annex II or III of the Regulation;the inclusion of the recommended MRLs in Annex II or III to the Regulation;the setting of specific processing factors as referred to in Article 20(2) of the Regulation.

The active substance and its use pattern {#efs25409-sec-0005}
========================================

Fluquinconazole is the common name for 3‐(2,4‐dichlorophenyl)‐6‐fluoro‐2‐(1*H*‐1,2,4‐triazol‐1‐yl)quinazolin‐4(3*H*)‐one (IUPAC).

Fluquinconazole belongs to the group of triazole compounds which are used as fungicides. It has a systemic activity by inhibiting ergosterol biosynthesis.

The chemical structures of fluquinconazole and its main metabolites are reported in Appendix [D](#efs25409-sec-1005){ref-type="sec"}.

Fluquinconazole was evaluated in the framework of Directive 91/414/EEC with Ireland designated as RMS (Ireland, [2005](#efs25409-bib-0006){ref-type="ref"}). The peer review process terminated following the notifiers decision to withdrew, in accordance with Article 11(e) of Commission Regulation (EC) No 1490/2002[7](#efs25409-note-1011){ref-type="fn"}, their support and fluquinconazole was not included in the Annex I to Directive 91/414/EEC through Commission Decision 2008/934/EC[8](#efs25409-note-1012){ref-type="fn"}. The applicant made a resubmission of the application under an accelerated procedure (Regulation (EC) No 33/2008[9](#efs25409-note-1013){ref-type="fn"}), the RMS evaluation of the additional data in the format of an Additional Report (Ireland, [2010](#efs25409-bib-0007){ref-type="ref"}) has been peer‐reviewed by EFSA (EFSA, [2011](#efs25409-bib-0002){ref-type="ref"}). The representative use supported for the peer review, was as fungicide on wheat. Following the peer‐review carried out by EFSA, a decision on inclusion of the active substance in Annex I to Directive 91/414/EEC was published by means of Commission Implementing Regulation (EU) No 806/2011, which entered into force on 1 January 2012. This approval is restricted to uses only as a fungicide. According to the Annex to the approval Regulation (EU) No 806/2011, the applicant was required to submit to the European Commission further studies in the area of residues and ecotoxicology by 31 December 2013. The confirmatory data relevant for the residue area were assessed in the EFSA technical Report on confirmatory data (EFSA, [2015](#efs25409-bib-0003){ref-type="ref"}).

The EU MRLs for fluquinconazole are established in Annex IIIA of Regulation (EC) No 396/2005 and codex maximum residue limits (CXLs) for this active substance are not available. For the purpose of this MRL review, no uses were reported. The RMS did not report any uses authorised in third countries that might have a significant impact on international trade.

Assessment {#efs25409-sec-0006}
==========

Considering that no uses are currently authorised for fluquinconazole within the EU, that no CXLs are available for this active substance and that no uses authorised in third countries were notified to the RMS, European consumers are not expected to be exposed to residues of this active substance and a consumer risk assessment is, in principle, not required. Risk managers might have interest, however, to enforce against the potential illegal use of fluquinconazole within the EU, as well as the presence of illegitimate residue levels in imported products.

Therefore, in order to assist risk managers in applying the most appropriate enforcement measures, EFSA assessed the available data with particular attention to the analytical methods, the toxicological reference values and the nature of residues in plants and livestock.

EFSA has based its assessment on the draft assessment report (DAR) and its addenda prepared under Council Directive 91/414/EEC (Ireland, [2005](#efs25409-bib-0006){ref-type="ref"}, [2010](#efs25409-bib-0007){ref-type="ref"}), the conclusion on the peer review of the pesticide risk assessment of the active substance fluquinconazole (EFSA, [2011](#efs25409-bib-0002){ref-type="ref"}) and the confirmatory data assessed following approval (Ireland, [2014](#efs25409-bib-0009){ref-type="ref"}; EFSA, [2015](#efs25409-bib-0003){ref-type="ref"}). The evaluation report submitted by the RMS in the framework of this review (Ireland, [2017](#efs25409-bib-0010){ref-type="ref"}) was considered as additional supporting information.

Primary crop metabolism of fluquinconazole was investigated in fruit crops (apple, grapes), root crops (carrots) and cereals (wheat) following foliar application, while rotational crop metabolism was investigated in cereals (wheat), leafy crops (lettuce) and root crops (radishes) (Ireland, [2005](#efs25409-bib-0006){ref-type="ref"}, [2010](#efs25409-bib-0007){ref-type="ref"}). Although triazole derivative metabolites (TDMs) were found at significant levels in the metabolism studies performed with the triazolyl label (especially in wheat grain and in rotational crops), parent fluquinconazole remained the predominant compound in all crops investigated, representing up to 95% total radioactive residue (TRR). Therefore, based on the available data and considering that TDMs are not specific for the active substance under assessment, parent compound only is considered to be the most adequate marker for enforcement against the potential illegal use of fluquinconazole in plants.

Livestock metabolism of fluquinconazole was investigated in lactating goat and in laying hens dosed with dichlorophenyl‐labelled fluquinconazole (Ireland, [2005](#efs25409-bib-0006){ref-type="ref"}). In ruminants, the parent constituted the predominant compound of the total residues in milk and in all tissues (accounting for up to 99% of the TRR). These results were partially confirmed by an additional metabolism study on goats performed with triazolyl‐labelled fluquinconazole and assessed as confirmatory data (Ireland, [2014](#efs25409-bib-0009){ref-type="ref"}). According to the results of this additional study, although 1,2,4‐triazole represented the main component of the TRR in milk (57% TRR) and kidney (62% of the TRR), parent fluquinconazole was always present at significant levels in milk and ruminant tissues ranging from 11% TRR (kidney) to 53% TRR (muscle). In poultry, parent fluquinconazole constituted the predominant compound of the total residues in eggs and in all tissues, accounting for up to 99.6% of the TRR. Since the metabolism in rats and ruminants was found to be similar, the main findings of the ruminants study can be extrapolated to pigs. Therefore, based on the available data and considering that 1,2,4‐triazole is not specific for the active substance under assessment, the parent compound is considered to be a valid marker for enforcement in all animal commodities against the potential illegal use of fluquinconazole. Since in the metabolism studies performed with dichlorophenyl‐labelled fluquinconazole, residues present in fat and in milk were almost exclusively represented by the parent molecule, this residue is to be considered as fat soluble.

Multi‐residues methods by using gas chromatography with electron capture detection (GC‐ECD) or liquid chromatography with tandem mass spectrometry (LC--MS/MS) were evaluated during the peer review and found to be sufficiently validated for the enforcement of fluquinconazole residues in plant commodities (high water, high acid, high fat content and dry matrices) at the limit of quantification (LOQ) of 0.01 mg/kg and in animal commodities at the LOQs of 0.02 mg/kg (muscle, fat, milk, eggs) and 0.05 mg/kg (liver and kidney) (EFSA, [2011](#efs25409-bib-0002){ref-type="ref"}). Analytical methods for enforcement in complex matrices were not assessed in the framework of the peer review.

During the completeness check, information on the availability of analytical methods for the enforcement of fluquinconazole was received by the EURLs (EURLs, [2018](#efs25409-bib-0005){ref-type="ref"}). On the basis of the information provided, QuEChERS (LC--MS/MS or gas chromatography with tandem mass spectrometry (GC--MS/MS)) multi‐residues methods are sufficiently validated in plant commodities (high water, high acid, high fat content and dry matrices), in eggs and in liver, at the LOQs of 0.01, 0.001 and 0.002 mg/kg, respectively. According to the EURLs, given the successful validation at such very low levels in liver and eggs it is supposed that an LOQ of 0.01 mg/kg will also be easily achieved in the remaining commodity groups of animal origin (muscle, kidney, milk) (EFSA, [2018](#efs25409-bib-0004){ref-type="ref"}; EURLs, [2018](#efs25409-bib-0005){ref-type="ref"}). Therefore, it is expected that fluquinconazole can be enforced with an LOQ of 0.01 mg/kg in all animal and plant commodities, except in complex matrices (e.g. tea, herbal infusions, cocoa, hops and spices). For these plant commodities, in the absence of fully validated analytical method, a higher LOQ of 0.05 mg/kg is tentatively proposed.

The toxicological assessment of fluquinconazole was peer reviewed under Directive 91/414/EEC, which resulted in an acceptable daily intake (ADI) and an acute reference dose (ARfD) being established at 0.002 mg/kg body weight (bw) per day and 0.02 mg/kg bw, respectively (EFSA, [2011](#efs25409-bib-0002){ref-type="ref"}).

In order to assess whether the reported LOQ values are sufficiently protective for European consumers, chronic and acute intake calculations were performed using revision 2 of the EFSA PRIMo (EFSA, [2007](#efs25409-bib-0001){ref-type="ref"}). These calculations were carried out assuming residues present at the LOQs of 0.05 mg/kg in complex matrices of plant origin and 0.01 mg/kg in all other plant commodities and in all commodities of animal origin.

The calculated exposures were compared with the toxicological reference values for fluquinconazole. The highest chronic exposure was calculated for French toddlers, representing 38% of the ADI, and the highest acute exposure was calculated for potatoes, representing 7.7% of the ARfD. EFSA highlights that this calculation does not reflect real exposure of consumers to fluquinconazole residues. This theoretical calculation only indicates that the above reported LOQ values would provide a satisfactory level of protection for European consumers.

Conclusions and recommendations {#efs25409-sec-0007}
===============================

Residues of fluquinconazole are not expected to occur in any plant commodity or in any animal product because no uses or import tolerances are currently authorised for fluquinconazole in the EU and no CXLs are available for this active substance. A risk assessment is therefore in principle not required.

Nevertheless, in order to assist risk managers in applying the most appropriate enforcement measures (against potential illegal uses), EFSA assessed the available data with particular attention to the analytical methods and the nature of residues in plants and livestock.

According to the results from the available metabolism studies in primary, rotational crops and in animals, parent compound is considered to be the most adequate marker for enforcement against the potential illegal use of fluquinconazole. It is expected that this compound can be enforced with an LOQ of 0.01 mg/kg in all animal and plant commodities, except in complex matrices (e.g. tea, herbal infusions, cocoa, hops and spices). For these plant commodities, in the absence of fully validated analytical method, a higher LOQ of 0.05 mg/kg is tentatively proposed.

Since in the metabolism studies performed with dichlorophenyl‐labelled fluquinconazole, residues present in fat and in milk were almost exclusively represented by the parent molecule, this residue is to be considered as fat soluble.

Considering that the enforcement against potential illegal uses falls under the remit of risk managers, EFSA is not in a position to recommend whether the default MRL of 0.01 mg/kg, as defined by Regulation (EC) No 396/2005, or whether the setting of specific LOQ values for plant and animal commodities should apply. It is noted however that for fluquinconazole, LOQ values of 0.05 mg/kg in complex matrices of plant origin and of 0.01 mg/kg in all other plant commodities and in animal commodities, would provide a satisfactory level of protection for the European consumers.

Abbreviations {#efs25409-sec-0008}
=============

a.s.active substanceADIacceptable daily intakeARfDacute reference doseBBCHgrowth stages of mono‐ and dicotyledonous plantsbwbody weightCACCodex Alimentarius CommissionCXLcodex maximum residue limitDARdraft assessment reportDATdays after treatmentDBdietary burdenEURLsEuropean Union Reference Laboratories for Pesticide Residues (former CRLs)GAPGood Agricultural PracticeGC‐ECDgas chromatography with electron capture detectorGC‐MS/MSgas chromatography with tandem mass spectrometryIEDIinternational estimated daily intakeIESTIinternational estimated short‐term intakeILVindependent laboratory validationISOInternational Organisation for StandardizationIUPACInternational Union of Pure and Applied ChemistryLC--MS/MSliquid chromatography with tandem mass spectrometryLOQlimit of quantificationMomonitoringMRLmaximum residue levelOECDOrganisation for Economic Co‐operation and DevelopmentPBIplant‐back intervalPRIMo(EFSA) Pesticide Residues Intake ModelPROFile(EFSA) Pesticide Residues Overview FileQuEChERSQuick, Easy, Cheap, Effective, Rugged, and Safe (analytical method)RArisk assessmentRDresidue definitionRMSrapporteur Member StateSMILESsimplified molecular‐input line‐entry systemTDMtriazole derivative metaboliteTRRtotal radioactive residue

Appendix A -- Summary of authorised uses considered for the review of MRLs {#efs25409-sec-1002}
==========================================================================

 {#efs25409-sec-0009}

Neither EU uses nor import tolerances are currently authorised for fluquinconazole.

Appendix B -- List of end points {#efs25409-sec-1003}
================================

B.1.. Residues in plants {#efs25409-sec-0010}
------------------------

### B.1.1.. Nature of residues and methods of analysis in plants {#efs25409-sec-0011}

#### B.1.1.1.. Metabolism studies, methods of analysis and residue definitions in plants {#efs25409-sec-0012}

Primary crops (available studies)Crop groupsCrop(s)Application(s)Sampling (DAT)Fruit cropsApplesDirect application on fruits, 3 × 10 or 100 g a.s./hl13GrapevinesDirect application on fruits, 1 × 7.5 or 75 g a.s./hl15; 28; 38Root cropsCarrotsFoliar, 1 × 161 or 587 g a.s./ha0; 20; 36CerealsWheatFoliar, 3 (BBCH 31; 39; 55) × 2,500 g a.s./haAt maturitySoil, 3 (BBCH 31; 39; 55) × 2,500 g a.s./haAt maturityStudies on fruit crops and carrots performed with dichlorophenyl label only. Study on spring wheat performed with dichlorophenyl‐ and triazolyl‐labelled fluquinconazole (Ireland, [2005](#efs25409-bib-0006){ref-type="ref"})Rotational crops (available studies)Crop groupsCrop(s)Application(s)PBI (DAT)Root/tuber cropsRadishBare soil, 750 g a.s./ha Bare soil, 250 g a.s./ha120 32Leafy cropsLettuceBare soil, 750 g a.s./ha Bare soil, 250 g a.s./ha120 32Cereal (small grain)WheatBare soil, 750 g a.s./ha Bare soil, 250 g a.s./ha120 32Study performed with dichlorophenyl‐ and triazolyl‐labelled fluquinconazole (Ireland, [2005](#efs25409-bib-0006){ref-type="ref"}, [2010](#efs25409-bib-0007){ref-type="ref"})Processed commodities (hydrolysis study)ConditionsInvestigated?Pasteurisation (20 min, 90°C, pH 4)YesBaking, brewing and boiling (60 min, 100°C, pH 5)YesSterilisation (20 min, 120°C, pH 6)NoMetabolites dione and 1,2,4‐triazole are formed during hydrolysis simulating baking, brewing and boiling but parent compound is still the predominant part of the residue. Sterilisation was not considered relevant for the representative use on wheat (Ireland, [2005](#efs25409-bib-0006){ref-type="ref"}, [2010](#efs25409-bib-0007){ref-type="ref"}; EFSA, [2011](#efs25409-bib-0002){ref-type="ref"})Can a general residue definition be proposed for primary crops?YesRotational crop and primary crop metabolism similar?YesResidue pattern in processed commodities similar to residue pattern in raw commodities?YesPlant residue definition for monitoring (RD‐Mo)FluquinconazolePlant residue definition for risk assessment (RD‐RA)Not relevant for enforcement against illegal usesConversion factor (monitoring to risk assessment)Not applicableMethods of analysis for monitoring of residues (analytical technique, crop groups, LOQs)High water, high acid, high fat content and dry matrices: QuEChERS (LC--MS/MS) LOQ: 0.01 mg/kg Validated in lettuce, wheat, oilseed rape, almonds, grape and orange Sources: EFSA ([2011](#efs25409-bib-0002){ref-type="ref"}); EURLs ([2018](#efs25409-bib-0005){ref-type="ref"})

### B.1.2.. Magnitude of residues in plants {#efs25409-sec-0013}

Not relevant since neither EU uses nor import tolerances are currently authorised for fluquinconazole.

B.2.. Residues in livestock {#efs25409-sec-0014}
---------------------------

### B.2.1.. Nature of residues and methods of analysis in livestock {#efs25409-sec-0015}

#### B.2.1.1.. Metabolism studies, methods of analysis and residue definitions in livestock {#efs25409-sec-0016}

Livestock (available studies)AnimalDose (mg/kg bw per day)Duration (days)N rate/commentLaying hen10 mg/kg feed14Study performed with dichlorophenyl‐labelled fluquinconazoleLactating goat10 mg/kg feed7Study performed with dichlorophenyl‐labelled fluquinconazole12 mg/kg feed12Nominal dose reported. Study performed with triazolyl‐labelled fluquinconazoleSources: Ireland ([2005](#efs25409-bib-0006){ref-type="ref"}, [2014](#efs25409-bib-0009){ref-type="ref"})Time needed to reach a plateau concentration in milk and eggs (days)Milk: 4--8 Eggs: 12Metabolism in rat and ruminant similar (Yes/No)YesAnimal residue definition for monitoring (RD‐Mo)FluquinconazoleAnimal residue definition for risk assessment (RD‐RA)Not relevant for enforcement against illegal usesConversion factor (monitoring to risk assessment)Not applicableFat soluble residues (Yes/No)YesMethods of analysis for monitoring of residues (analytical technique, crop groups, LOQs)Muscle, fat, milk and eggs: Multi‐residues DFG S19 (GC‐ECD) LOQ: 0.02 mg/kg Source: EFSA ([2011](#efs25409-bib-0002){ref-type="ref"}) Kidney, liver: GC‐ECD LOQ: 0.05 mg/kg ILV not available Source: EFSA ([2011](#efs25409-bib-0002){ref-type="ref"}) According to the EURLs, although QuEChERS (GC--MS/MS) validation data are only available for liver and eggs, an LOQ of 0.01 mg/kg is expected to be achievable in all animal commodities (EFSA, [2018](#efs25409-bib-0004){ref-type="ref"}; EURLs, [2018](#efs25409-bib-0005){ref-type="ref"})[^1]

### B.2.2.. Magnitude of residues in livestock {#efs25409-sec-0017}

Not relevant since neither EU uses nor import tolerances are currently authorised for fluquinconazole.

B.3.. Consumer risk assessment {#efs25409-sec-0018}
------------------------------

### B.3.1.. Consumer risk assessment {#efs25409-sec-0019}

ADI0.002 mg/kg bw per day (EFSA, [2011](#efs25409-bib-0002){ref-type="ref"})Highest IEDI, according to EFSA PRIMo38% ADI (FR, toddlers)Assumptions made for the calculationsThe calculation is based on the LOQs for enforcement according to the available analytical methodsARfD0.02 mg/kg bw (EFSA, [2011](#efs25409-bib-0002){ref-type="ref"})Highest IESTI, according to EFSA PRIMo7.7% ARfD (potatoes)Assumptions made for the calculationsThe calculation is based on the LOQs for enforcement according to the available analytical methods[^2]

Appendix C -- Pesticide Residue Intake Model (PRIMo) {#efs25409-sec-1004}
====================================================

 {#efs25409-sec-0020}

PRIMo(EU)

![](EFS2-16-e05409-g001){#efs25409-fig-0001}

Appendix D -- Used compound codes {#efs25409-sec-1005}
=================================

 {#efs25409-sec-0021}

Code/trivial name[a](#efs25409-note-1018){ref-type="fn"}IUPAC name/SMILES notation/InChiKey[b](#efs25409-note-1019){ref-type="fn"}Structural formula[c](#efs25409-note-1020){ref-type="fn"}Fluquinconazole3‐(2,4‐dichlorophenyl)‐6‐fluoro‐2‐(1*H*‐1,2,4‐triazol‐1‐yl)quinazolin‐4(3*H*)‐one Fc1ccc2N=C(n3ncnc3)N(c4ccc(Cl)cc4Cl)C(=O)c2c1 IJJVMEJXYNJXOJ‐UHFFFAOYSA‐N![](EFS2-16-e05409-g002.jpg "image")1,2,4‐triazole1*H*‐1,2,4‐triazole N1N=CN=C1 NSPMIYGKQJPBQR‐UHFFFAOYSA‐N![](EFS2-16-e05409-g003.jpg "image")[^3][^4][^5][^6]

Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC. OJ L 70, 16.3.2005, p. 1--16.

Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market. OJ L 230, 19.8.1991, p. 1--32. Repealed by Regulation (EC) No 1107/2009.

Commission Implementing Regulation (EU) No 806/2011 of 10 August 2011 approving the active substance fluquinconazole, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 and Commission Decision 2008/934/EC. OJ L 206, 11.8.2011, p. 39--43.

Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC. OJ L 309, 24.11.2009, p. 1--50.
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